Pegylated interferon alpha2b versus pegylated interferon alpha2a for chronic hepatitis C: the unreached goal of superiority.
Rumi
Maria Grazia
MG
1st Division of Gastroenterology, Fondazione IRCCS Maggiore Hospital Mangiagalli e Regina Elena, A.M. Migliavacca Center for Liver Disease, Università degli Studi di Milano, Via F. Sforza 35, 20122 Milan, Italy.